New Delhi: HL November 9, 2026
In a major relief for cancer patients and their families, revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer medicine formulations have come into effect across India from November 9, 2026. The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on 137 anti-cancer drugs to make life-saving medicines more affordable.
According to the Ministry of Chemicals and Fertilizers, 85 pharmaceutical companies have reported revised prices covering 121 drugs as of November 8. Notably, 679 brands have reported price reductions of more than 50%, while the highest reported reduction in MRP stands at 96.45%.
The move is expected to generate annual savings of approximately ₹3,540.38 crore for consumers, providing significant financial relief to cancer patients who often face high treatment and medication costs.
The revised prices have been implemented following recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS) on October 17, 2026.
How to Check Revised Cancer Drug Prices
Consumers can verify the revised MRP printed on medicine packs or check prices through:
- Pharma Sahi Daam mobile application
- NPPA official website: https://nppa.gov.in
Chemists and hospital pharmacies cannot charge more than the revised MRP.
Where to Report Overcharging
Consumers can register complaints through the Pharma Jan Samadhan portal or contact the NPPA helpline at 1800-111-255.
The initiative is an important step towards improving access to affordable cancer treatment and reducing the financial burden on patients and their families.
